Genetic and environmental influences on systemic markers of inflammation in middle-aged male twins. 2008

Shaoyong Su, and Harold Snieder, and Andrew H Miller, and James Ritchie, and J Douglas Bremner, and Jack Goldberg, and Jun Dai, and Linda Jones, and Nancy V Murrah, and Jinying Zhao, and Viola Vaccarino
Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30306, USA.

OBJECTIVE The aims of this study were to determine the relative influence of genetic and environmental contributions to inflammatory biomarkers, and to what extent correlations among these markers are due to genetic or environmental factors. METHODS We performed univariate and multivariate genetic analyses of four inflammatory markers: interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R), C-reactive protein (CRP), and fibrinogen, in 166 (88 monozygotic and 78 dizygotic) middle-aged male twin pairs. RESULTS The mean age (+/-S.D.) of the twins was 54 (+/-2.93) years. Heritability was substantial for CRP (0.61, 95% CI: 0.47-0.72) and moderate to fair for IL-6 (0.31, 0.13-0.46), sIL-6R (0.49, 0.30-0.76) and fibrinogen (0.52, 0.34-0.65). IL-6, CRP and fibrinogen showed significant correlations, but not with sIL-6R. Multivariate genetic analysis found that these correlations could be best explained by a common pathway model, where the common factor explained 27%, 73% and 25% of the variance of IL-6, CRP and fibrinogen, respectively. About 46% (95% CI: 21-64%) of the correlations among the three inflammatory markers could be explained by the genetic factors. After adjusting for covariates known to influence inflammation levels, heritability estimates were slightly decreased but the overall results remained similar. CONCLUSIONS A significant part of the variation in inflammatory marker levels is due to genetic influences. Furthermore, almost 50% of the shared variance among these biomarkers is due to a common genetic factor which likely plays a key role in the regulation of inflammation.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014427 Twins Two individuals derived from two FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother. Twins are either monozygotic (TWINS, MONOZYGOTIC) or dizygotic (TWINS, DIZYGOTIC). Twin
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

Shaoyong Su, and Harold Snieder, and Andrew H Miller, and James Ritchie, and J Douglas Bremner, and Jack Goldberg, and Jun Dai, and Linda Jones, and Nancy V Murrah, and Jinying Zhao, and Viola Vaccarino
September 2014, Arteriosclerosis, thrombosis, and vascular biology,
Shaoyong Su, and Harold Snieder, and Andrew H Miller, and James Ritchie, and J Douglas Bremner, and Jack Goldberg, and Jun Dai, and Linda Jones, and Nancy V Murrah, and Jinying Zhao, and Viola Vaccarino
July 2007, Vision research,
Shaoyong Su, and Harold Snieder, and Andrew H Miller, and James Ritchie, and J Douglas Bremner, and Jack Goldberg, and Jun Dai, and Linda Jones, and Nancy V Murrah, and Jinying Zhao, and Viola Vaccarino
October 1999, The American journal of clinical nutrition,
Shaoyong Su, and Harold Snieder, and Andrew H Miller, and James Ritchie, and J Douglas Bremner, and Jack Goldberg, and Jun Dai, and Linda Jones, and Nancy V Murrah, and Jinying Zhao, and Viola Vaccarino
March 2005, The American journal of clinical nutrition,
Shaoyong Su, and Harold Snieder, and Andrew H Miller, and James Ritchie, and J Douglas Bremner, and Jack Goldberg, and Jun Dai, and Linda Jones, and Nancy V Murrah, and Jinying Zhao, and Viola Vaccarino
August 2004, Sleep,
Shaoyong Su, and Harold Snieder, and Andrew H Miller, and James Ritchie, and J Douglas Bremner, and Jack Goldberg, and Jun Dai, and Linda Jones, and Nancy V Murrah, and Jinying Zhao, and Viola Vaccarino
August 2000, The journals of gerontology. Series A, Biological sciences and medical sciences,
Shaoyong Su, and Harold Snieder, and Andrew H Miller, and James Ritchie, and J Douglas Bremner, and Jack Goldberg, and Jun Dai, and Linda Jones, and Nancy V Murrah, and Jinying Zhao, and Viola Vaccarino
November 1998, Drug and alcohol dependence,
Shaoyong Su, and Harold Snieder, and Andrew H Miller, and James Ritchie, and J Douglas Bremner, and Jack Goldberg, and Jun Dai, and Linda Jones, and Nancy V Murrah, and Jinying Zhao, and Viola Vaccarino
December 2003, Journal of abnormal child psychology,
Shaoyong Su, and Harold Snieder, and Andrew H Miller, and James Ritchie, and J Douglas Bremner, and Jack Goldberg, and Jun Dai, and Linda Jones, and Nancy V Murrah, and Jinying Zhao, and Viola Vaccarino
August 2007, American journal of physiology. Heart and circulatory physiology,
Shaoyong Su, and Harold Snieder, and Andrew H Miller, and James Ritchie, and J Douglas Bremner, and Jack Goldberg, and Jun Dai, and Linda Jones, and Nancy V Murrah, and Jinying Zhao, and Viola Vaccarino
October 2013, Journal of sleep research,
Copied contents to your clipboard!